Submit
Search
Submit
Menu

  • Information

  • References

  • Contents

  • [1]J. Dalmau, E. Tuzun, H. Y. Wu, J. Masjuan, J. E. Rossi, A. Voloschin, J. M. Baehring, H. Shimazaki, R. Koide, D. King, W. Mason, L. H. Sansing, M. A. Dichter, M. R. Rosenfeld and D. R. Lynch: Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol, 61(1), 25-36 (2007)

  • [2]M. J. Titulaer, L. McCracken, I. Gabilondo, T. Armangue, C. Glaser, T. Iizuka, L. S. Honig, S. M. Benseler, I. Kawachi, E. Martinez-Hernandez, E. Aguilar, N. Gresa-Arribas, N. Ryan-Florance, A. Torrents, A. Saiz, M. R. Rosenfeld, R. Balice-Gordon, F. Graus and J. Dalmau: Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol, 12(2), 157-65 (2013)

  • [3]H. Wang and W. H. Li: Increasing MicroRNA target prediction confidence by the relative R(2) method. J Theor Biol, 259(4), 793-8 (2009)

  • [4]W. J. Hsieh, F. M. Lin, H. D. Huang and H. Wang: Investigating microRNA-target interaction-supported tissues in human cancer tissues based on miRNA and target gene expression profiling. PLoS One, 9(4), e95697 (2014)

  • [5]H. Wang: Predicting cancer-related MiRNAs using expression profiles in tumor tissue. Curr Pharm Biotechnol, 15(5), 438-44 (2014)

  • [6]S. M. Lehmann, C. Kruger, B. Park, K. Derkow, K. Rosenberger, J. Baumgart, T. Trimbuch, G. Eom, M. Hinz, D. Kaul, P. Habbel, R. Kalin, E. Franzoni, A. Rybak, D. Nguyen, R. Veh, O. Ninnemann, O. Peters, R. Nitsch, F. L. Heppner, D. Golenbock, E. Schott, H. L. Ploegh, F. G. Wulczyn and S. Lehnardt: An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration. Nat Neurosci, 15(6), 827-35 (2012)

  • [7]J. Zhang, X. Xu, S. Zhao, Z. Gong, P. Liu, W. Guan, X. He, T. Wang, T. Peng, J. Teng and Y. Jia: The Expression and Significance of the Plasma Let-7 Family in Anti-N-methyl-D-aspartate Receptor Encephalitis. J Mol Neurosci (2015)

  • [8]G. A. Calin, C. Sevignani, C. D. Dumitru, T. Hyslop, E. Noch, S. Yendamuri, M. Shimizu, S. Rattan, F. Bullrich, M. Negrini and C. M. Croce: Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A, 101(9), 2999-3004 (2004)

  • [9]M. Kurian, P. H. Lalive, J. O. Dalmau and J. Horvath: Opsoclonus-myoclonus syndrome in anti-N-methyl-D-aspartate receptor encephalitis. Arch Neurol, 67(1), 118-21 (2010)

  • [10]Y. Hachiya, A. Uruha, E. Kasai-Yoshida, K. Shimoda, I. Satoh-Shirai, S. Kumada, E. Kurihara, K. Suzuki, A. Ohba, S. Hamano and H. Sakuma: Rituximab ameliorates anti-N-methyl-D-aspartate receptor encephalitis by removal of short-lived plasmablasts. J Neuroimmunol, 265(1-2), 128-30 (2013)

  • [11]J. W. Lo, E. Y. Leung, B. L. Ng, M. H. Fu, K. K. Yip, R. T. Chan and C. M. Chang: Anti-N-methyl-D-aspartate receptor encephalitis in a young woman with an ovarian tumour. Hong Kong Med J, 16(4), 313-6 (2010)

  • [12]H. Wang and Y. C. Lin: RankResponse: Ranking Responses in a Single Response Question or a Multiple Response Question. R package version 3.1.1. (2014)

  • [13]H. Wang: Ranking responses in multiple-choice questions. Journal of Applied Statistics, 35(4), 465-474 (2008)

  • [14]C. W. Beatty, C. J. Creutzfeldt, A. P. Davis, Z. Hoffer and S. P. Khot: The diagnostic conundrum and treatment dilemma of a patient with a rapidly progressive encephalopathy. Neurohospitalist, 4(1), 34-41 (2014)

  • [15]A. Thomas, P. Rauschkolb, N. Gresa-Arribas, A. Schned, J. O. Dalmau and C. E. Fadul: Anti-N-methyl-D-aspartate receptor encephalitis: a patient with refractory illness after 25 months of intensive immunotherapy. JAMA Neurol, 70(12), 1566-8 (2013)

  • [16]O. Sanmaneechai, J. L. Song, N. Nevadunsky, S. L. Moshe and P. J. Overby: Anti-N-methyl-d-aspartate encephalitis with ovarian cystadenofibroma. Pediatr Neurol, 48(3), 232-5 (2013)

  • [17]S. U. Jantzen, S. Ferrea, C. Wach, K. Quasthoff, S. Illes, D. Scherfeld, H. P. Hartung, R. J. Seitz and M. Dihne: In vitro neuronal network activity in NMDA receptor encephalitis. BMC Neurosci, 14, 17 (2013)

  • [18]H. C. Hansen, C. Klingbeil, J. Dalmau, W. Li, B. Weissbrich and K. P. Wandinger: Persistent intrathecal antibody synthesis 15 years after recovering from anti-N-methyl-D-aspartate receptor encephalitis. JAMA Neurol, 70(1), 117-9 (2013)

  • [19]W. K. Van Putten, S. Hachimi-Idrissi, A. Jansen, V. Van Gorp and L. Huyghens: Uncommon cause of psychotic behavior in a 9-year-old girl: a case report. Case Rep Med, 2012, 358520 (2012)

  • [20]P. Maggina, M. Mavrikou, S. Karagianni, C. L. Skevaki, A. Triantafyllidou, C. Voudris, E. Katsarou, L. Stamogiannou and S. Mastroyianni: Anti-N-methyl-D-aspartate receptor encephalitis presenting with acute psychosis in a preteenage girl: a case report. J Med Case Rep, 6, 224 (2012)

  • [21]C. L. Xu, L. Liu, W. Q. Zhao, J. M. Li, R. J. Wang, S. H. Wang, D. X. Wang, M. Y. Liu, S. S. Qiao and J. W. Wang: Anti-N-methyl-D-aspartate receptor encephalitis with serum anti-thyroid antibodies and IgM antibodies against Epstein-Barr virus viral capsid antigen: a case report and one year follow-up. BMC Neurol, 11, 149 (2011)

  • [22]E. M. Goldberg, K. S. Taub, S. K. Kessler and N. S. Abend: Anti-NMDA receptor encephalitis presenting with focal non-convulsive status epilepticus in a child. Neuropediatrics, 42(5), 188-90 (2011)

  • [23]A. Consoli, K. Ronen, I. An-Gourfinkel, M. Barbeau, D. Marra, N. Costedoat-Chalumeau, D. Montefiore, P. Maksud, O. Bonnot, A. Didelot, Z. Amoura, M. Vidailhet and D. Cohen: Malignant catatonia due to anti-NMDA-receptor encephalitis in a 17-year-old girl: case report. Child Adolesc Psychiatry Ment Health, 5(1), 15 (2011)

  • [24]N. Luca, T. Daengsuwan, J. Dalmau, K. Jones, G. deVeber, J. Kobayashi, R. M. Laxer and S. M. Benseler: Anti-N-methyl-D-aspartate receptor encephalitis: a newly recognized inflammatory brain disease in children. Arthritis Rheum, 63(8), 2516-22 (2011)

  • [25]N. Johnson, C. Henry, A. J. Fessler and J. Dalmau: Anti-NMDA receptor encephalitis causing prolonged nonconvulsive status epilepticus. Neurology, 75(16), 1480-2 (2010)

  • [26]L. C. Wong-Kisiel, T. Ji, D. L. Renaud, S. Kotagal, M. C. Patterson, J. Dalmau and K. J. Mack: Response to immunotherapy in a 20-month-old boy with anti-NMDA receptor encephalitis. Neurology, 74(19), 1550-1 (2010)

  • [27]S. Ferioli, J. Dalmau, C. A. Kobet, Q. J. Zhai, J. P. Broderick and A. J. Espay: Anti-N-methyl-D-aspartate receptor encephalitis: characteristic behavioral and movement disorder. Arch Neurol, 67(2), 250-1 (2010)

  • [28]N. R. Florance, R. L. Davis, C. Lam, C. Szperka, L. Zhou, S. Ahmad, C. J. Campen, H. Moss, N. Peter, A. J. Gleichman, C. A. Glaser, D. R. Lynch, M. R. Rosenfeld and J. Dalmau: Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol, 66(1), 11-8 (2009)

  • [29]M. Seki, S. Suzuki, T. Iizuka, T. Shimizu, Y. Nihei, N. Suzuki and J. Dalmau: Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis. J Neurol Neurosurg Psychiatry, 79(3), 324-6 (2008)

  • [30]M. Appu and M. Noetzel: Clinically significant response to zolpidem in disorders of consciousness secondary to anti-N-methyl-D-aspartate receptor encephalitis in a teenager: a case report. Pediatr Neurol, 50(3), 262-4 (2014)

  • [31]E. M. Goldberg, M. Titulaer, P. M. de Blank, A. Sievert and N. Ryan: Anti-N-methyl-D-aspartate receptor-mediated encephalitis in infants and toddlers: case report and review of the literature. Pediatr Neurol, 50(2), 181-4 (2014)

  • [32]I. B. Marques, R. Teotonio, C. Cunha, C. Bento and F. Sales: Anti-NMDA receptor encephalitis presenting with total insomnia--a case report. J Neurol Sci, 336(1-2), 276-80 (2014)

  • [33]S. Nijmeijer, S. Bontemps, L. Naeije and J. Coutinho: Anti-N-methyl-D-aspartate receptor encephalitis in a pre-teenage girl: a case report. Eur J Pediatr, 173(5), 681-3 (2014)

  • [34]V. Cantarin-Extremera, A. Duat-Rodriguez, L. Gonzalez-Gutierrez-Solana, L. Lopez-Marin and T. Armangue: Clinical case of anti-N-methyl-D-aspartate receptor encephalitis in an 8-month-old patient with hyperkinetic movement disorder. Pediatr Neurol, 48(5), 400-2 (2013)

  • [35]L. Safadieh and O. Dabbagh: Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis in a young Lebanese girl. J Child Neurol, 28(10), 1222-5 (2013)

  • [36]H. Suzuki, M. Kitada, S. Ueno, K. Tanaka and S. Kusunoki: Anti-NMDAR encephalitis preceded by dura mater lesions. Neurol Sci, 34(6), 1021-2 (2013)

  • [37]S. Raha, P. Gadgil, C. Sankhla and V. Udani: Nonparaneoplastic anti-N-methyl-D-aspartate receptor encephalitis: a case series of four children. Pediatr Neurol, 46(4), 246-9 (2012)

  • [38]S. Lebon, C. Mayor-Dubois, I. Popea, C. Poloni, N. Selvadoray, A. Gumy and E. Roulet-Perez: Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis mimicking a primary psychiatric disorder in an adolescent. J Child Neurol, 27(12), 1607-10 (2012)

  • [39]A. Takeda, H. Shimada, A. Tamura, M. Yasui, K. Yamamoto, K. Itoh, S. Ataka, S. Tanaka, M. Ohsawa, H. Hatsuta, M. Hirano, H. Sakamoto, S. Ueno, Y. Nakamura, T. Tsutada and T. Miki: A case of anti-N-methyl-d-aspartate receptor encephalitis with multiple sclerosis-like demyelinated lesions. Mult Scler Relat Disord, 3(3), 391-7 (2014)

  • [40]Y. H. Guo, T. S. Kuan, P. C. Hsieh, W. C. Lien, C. K. Chang and Y. C. Lin: Rehabilitation for a child with recalcitrant anti-N-methyl-d-aspartate receptor encephalitis: case report and literature review. Neuropsychiatr Dis Treat, 10, 2263-7 (2014)

  • [41]S. Kaur, M. Juneja, D. Mishra and S. Jain: Anti-N-methyl-D-aspartate receptor encephalitis: A case report and review of the literature. J Pediatr Neurosci, 9(2), 145-7 (2014)

  • [42]T. Y. Hung, N. H. Foo and M. C. Lai: Anti-N-methyl-d-aspartate receptor encephalitis. Pediatr Neonatol, 52(6), 361-4 (2011)

  • [43]A. Salvucci, I. M. Devine, D. Hammond and R. D. Sheth: Pediatric anti-NMDA (N-methyl D-aspartate) receptor encephalitis. Pediatr Neurol, 50(5), 507-10 (2014)

  • [44]D. Aguiar de Sousa, P. P. Lobo, A. C. Caldas, M. Coelho and L. Albuquerque: Pure ataxia associated with N-methyl-D-aspartate receptor antibodies. Parkinsonism Relat Disord, 20(5), 568-9 (2014)

  • [45]O. Outteryck, G. Baille, J. Hodel, M. Giroux, A. Lacour, J. Honnorat, H. Zephir and P. Vermersch: Extensive myelitis associated with anti-NMDA receptor antibodies. BMC Neurol, 13, 211 (2013)

  • [46]D. Di Capua, S. Garcia-Ptacek, M. E. Garcia-Garcia, B. Abarrategui, J. Porta-Etessam and I. Garcia-Morales: Extreme delta brush in a patient with anti-NMDAR encephalitis. Epileptic Disord, 15(4), 461-4 (2013)

  • [47]S. Ramanathan, S. S. Mohammad, F. Brilot and R. C. Dale: Autoimmune encephalitis: recent updates and emerging challenges. J Clin Neurosci, 21(5), 722-30 (2014)

  • [48]M. Mirabelli-Badenier, R. Biancheri, G. Morana, S. Fornarino, L. Siri, M. E. Celle, E. Veneselli, A. Vincent, R. Gaggero and M. M. Mancardi: Anti-NMDAR encephalitis misdiagnosed as Hashimoto’s encephalopathy. Eur J Paediatr Neurol, 18(1), 72-4 (2014)

  • [49]M. L. Yau and E. L. Fung: Early consideration of anti-NMDAR encephalitis in unexplained encephalopathy. Hong Kong Med J, 19(4), 362-4 (2013)

  • [50]Y. Tsuyusaki, R. Sakakibara, M. Kishi, F. Tateno and T. Yoshida: Downbeat nystagmus as the initial manifestation of anti-NMDAR encephalitis. Neurological Sciences, 35(1), 125-126 (2014)

  • [51]J. E. Wilson, J. Shuster and C. Fuchs: Anti-NMDA receptor encephalitis in a 14-year-old female presenting as malignant catatonia: medical and psychiatric approach to treatment. Psychosomatics, 54(6), 585-9 (2013)

  • [52]N. Dericioglu, A. Vural, P. Acar, N. Agayeva, V. Ismailova, A. Kurne, E. Saka, E. M. Arsava and M. A. Topcuoglu: Antiepileptic treatment for anti-NMDA receptor encephalitis: the need for video-EEG monitoring. Epileptic Disord, 15(2), 166-70 (2013)

  • [53]R. Kumar, D. Gunaratne, S. Khan, K. Crawford, M. Cook and R. Tuck: Acute neuropsychiatric manifestations of anti-N-methyl-D-aspartate receptor encephalitis. Australas Psychiatry, 21(3), 279-80 (2013)

  • [54]M. M. Esseveld, E. H. van de Riet, L. Cuypers and J. N. Schieveld: Drawings during neuropsychiatric recovery from anti-NMDA receptor encephalitis. Am J Psychiatry, 170(1), 21-2 (2013)

  • [55]H. E. Hinson, C. Takahashi, G. Altowaijri, I. J. Baguley and D. Bourdette: Anti-NMDA receptor encephalitis with paroxysmal sympathetic hyperactivity: an under-recognized association? Clin Auton Res, 23(2), 109-11 (2013)

  • [56]R. C. Dale, S. Pillai and F. Brilot: Cerebrospinal fluid CD19(+) B-cell expansion in N-methyl-D-aspartate receptor encephalitis. Dev Med Child Neurol, 55(2), 191-3 (2013)

  • [57]X. Finne Lenoir, C. Sindic, V. van Pesch, S. El Sankari, M. de Tourtchaninoff, R. Denays and P. Hantson: Anti-N-methyl-D-aspartate receptor encephalitis with favorable outcome despite prolonged status epilepticus. Neurocrit Care, 18(1), 89-92 (2013)

  • [58]A. Vural, E. M. Arsava, N. Dericioglu and M. A. Topcuoglu: Central Neurogenic Hyperventilation in Anti-NMDA Receptor Encephalitis. Internal Medicine, 51(19), 2789-2792 (2012)

  • [59]H. Aoki, S. Morita, N. Miura, T. Tsuji, Y. Ohnuki, Y. Nakagawa, I. Yamamoto, H. Takahashi and S. Inokuchi: Early diagnosis of anti-N-methyl-D-aspartate receptor encephalitis in a young woman with psychiatric symptoms. Tokai J Exp Clin Med, 37(3), 89-93 (2012)

  • [60]A. Mann, N. M. Machado, N. Liu, A. H. Mazin, K. Silver and K. I. Afzal: A Multidisciplinary Approach to the Treatment of Anti-NMDA-Receptor Antibody Encephalitis: A Case and Review of the Literature. Journal of Neuropsychiatry and Clinical Neurosciences, 24(2), 247-254 (2012)

  • [61]R. Salazar, E. James, M. Elsayed, P. Varelas, J. Bartscher, J. Corry and T. Abdelhak: Profuse sialorrhea in a case of anti N-methyl-D-aspartate receptor (NMDAR) encephalitis. Clin Neurol Neurosurg, 114(7), 1066-9 (2012)

  • [62]J. L. Tanyi, E. B. Marsh, J. Dalmau and C. S. Chu: Reversible paraneoplastic encephalitis in three patients with ovarian neoplasms. Acta Obstet Gynecol Scand, 91(5), 630-4 (2012)

  • [63]E. Tuzun, R. Turkoglu, S. M. Yumerhodzha, E. Erdag, M. Eraksoy and G. Akman-Demir: Anti-N-methyl-D-aspartate receptor encephalitis with minimal cortical impairment. Neurological Sciences, 34(1), 111-113 (2013)

  • [64]R. Shah, A. Veerapandiyan, S. Winchester, W. Gallentine and M. A. Mikati: Two Patients With an Anti-N-Methyl-D-Aspartate Receptor Antibody Syndrome-Like Presentation and Negative Results of Testing for Autoantibodies. Pediatric Neurology, 45(6), 412-416 (2011)

  • [65]A. Y. X. Yu and F. G. A. Moore: Paraneoplastic Encephalitis Presenting as Postpartum Psychosis. Psychosomatics, 52(6), 568-570 (2011)

  • [66]A. Uruha, Y. Kitazawa, M. Kuroda, K. Tanaka and R. Koide: Anti-NMDAR encephalitis in small-cell lung cancer: A case report. Clinical Neurology and Neurosurgery, 114(3), 260-261 (2012)

  • [67]A. Sameshima, T. Hidaka, T. Shima, A. Nakashima, T. Hasegawa and S. Saito: Anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian immature teratoma. Journal of Obstetrics and Gynaecology Research, 37(12), 1883-1886 (2011)

  • [68]M. Lee, N. Lawn, D. Prentice and J. Chan: Anti-NMDA receptor encephalitis associated with ictal asystole. Journal of Clinical Neuroscience, 18(12), 1716-1718 (2011)

  • [69]H. Suzuki, M. Samukawa, M. Kitada, J. Ichihashi, Y. Mistui, K. Tanaka and S. Kusunoki: A case of anti-N-methyl-D-aspartate receptor encephalitis with systemic sclerosis. European Journal of Neurology, 18(11), E145-E146 (2011)

  • [70]H. Barry, O. Hardiman, D. G. Healy, M. Keogan, J. Moroney, P. P. Molnar, D. R. Cotter and K. C. Murphy: Anti-NMDA receptor encephalitis: an important differential diagnosis in psychosis. Br J Psychiatry, 199(6), 508-9 (2011)

  • [71]J. Pascual-Ramirez, J. J. Munoz-Torrero, L. Bacci, S. G. Trujillo and N. Garcia-Serrano: Anesthetic management of ovarian teratoma excision associated with anti-N-methyl-D-aspartate receptor encephalitis. Int J Gynaecol Obstet, 115(3), 291-2 (2011)

  • [72]P. Kashyape, E. Taylor, J. Ng, D. Krishnakumar, F. Kirkham and A. Whitney: Successful treatment of two paediatric cases of anti-NMDA receptor encephalitis with cyclophosphamide: the need for early aggressive immunotherapy in tumour negative paediatric patients. Eur J Paediatr Neurol, 16(1), 74-8 (2012)

  • [73]I. Naoura, A. Didelot, F. Walker, D. Luton and M. Koskas: Anti-N-methyl-D-aspartate receptor encephalitis complicating ovarian teratomas: a case report. Am J Obstet Gynecol, 205(4), e6-8 (2011)

  • [74]K. J. Frawley, M. A. Calvo-Garcia, D. A. Krueger and R. L. McMasters: “Benign’ ovarian teratoma and N-methyl-D-aspartate receptor (NMDAR) encephalitis in a child. Pediatric Radiology, 42(1), 120-123 (2012)

  • [75]H. Kawano, E. Hamaguchi, S. Kawahito, Y. M. Tsutsumi, K. Tanaka, H. Kitahata and S. Oshita: Anaesthesia for a patient with paraneoplastic limbic encephalitis with ovarian teratoma: relationship to anti-N-methyl-D-aspartate receptor antibodies. Anaesthesia, 66(6), 515-8 (2011)

  • [76]A. Uchino, T. Iizuka, Y. Urano, M. Arai, A. Hara, J. Hamada, R. Hirose, J. Dalmau and H. Mochizuki: Pseudo-piano playing motions and nocturnal hypoventilation in anti-NMDA receptor encephalitis: response to prompt tumor removal and immunotherapy. Intern Med, 50(6), 627-30 (2011)

  • [77]H. Alexopoulos, M. L. Kosmidis, J. Dalmau and M. C. Dalakas: Paraneoplastic anti-NMDAR encephalitis: long term follow-up reveals persistent serum antibodies. Journal of Neurology, 258(8), 1568-1570 (2011)

  • [78]E. S. Frechette, L. Zhou, S. L. Galetta, L. Chen and J. Dalmau: Prolonged Follow-up and CSF Antibody Titers in a Patient With Anti-NMDA Receptor Encephalitis. Neurology, 76(7), S64-S66 (2011)

  • [79]J. J. Millichap, J. L. Goldstein, L. C. Laux, D. R. Nordli, Jr., C. V. Stack and M. S. Wainwright: Ictal asystole and anti-N-methyl-D-aspartate receptor antibody encephalitis. Pediatrics, 127(3), e781-6 (2011)

  • [80]G. S. Day, S. M. High, B. Cot and D. F. Tang-Wai: Anti-NMDA-receptor encephalitis: case report and literature review of an under-recognized condition. J Gen Intern Med, 26(7), 811-6 (2011)

  • [81]M. Hara, A. Morita, S. Kamei, M. Yamaguchi, T. Homma, N. Nemoto, K. Sugita, T. Yamamoto and J. Dalmau: Anti-N-methyl-D-aspartate receptor encephalitis associated with carcinosarcoma with neuroendocrine differentiation of the uterus. J Neurol, 258(7), 1351-3 (2011)

  • [82]M. P. Kirkpatrick, C. D. Clarke, H. H. Sonmezturk and B. Abou-Khalil: Rhythmic delta activity represents a form of nonconvulsive status epilepticus in anti-NMDA receptor antibody encephalitis. Epilepsy Behav, 20(2), 392-4 (2011)

  • [83]N. Tachibana, T. Shirakawa, K. Ishii, Y. Takahashi, K. Tanaka, K. Arima, T. Yoshida and S. Ikeda: Expression of Various Glutamate Receptors Including N-Methyl-D-Aspartate Receptor (NMDAR) in an Ovarian Teratoma Removed from a Young Woman with Anti-NMDAR Encephalitis. Internal Medicine, 49(19), 2167-2173 (2010)

  • [84]S. H. S. Chan, V. C. N. Wong, C. W. Fung, R. C. Dale and A. Vincent: Anti-NMDA Receptor Encephalitis With Atypical Brain Changes on MRI. Pediatric Neurology, 43(4), 274-278 (2010)

  • [85]A. P. Lesher, T. J. Myers, F. Tecklenburg and C. J. Streck: Anti-N-methyl-D-aspartate receptor encephalitis associated with an ovarian teratoma in an adolescent female. Journal of Pediatric Surgery, 45(7), 1550-1553 (2010)

  • [86]M. A. Kumar, A. Jain, V. E. Dechant, T. Saito, T. Rafael, H. Aizawa, K. C. Dysart, T. Katayama, Y. Ito, N. Araki, T. Abe, R. Balice-Gordon and J. Dalmau: Anti-N-methyl-D-aspartate Receptor Encephalitis During Pregnancy. Archives of Neurology, 67(7), 884-887 (2010)

  • [87]T. Iizuka, S. Yoshii, S. Kan, J. Hamada, J. Dalmau, F. Sakai and H. Mochizuki: Reversible brain atrophy in anti-NMDA receptor encephalitis: a long-term observational study. J Neurol, 257(10), 1686-91 (2010)

  • [88]E. H. Breese, J. Dalmau, V. A. Lennon, M. Apiwattanakul and D. K. Sokol: Anti-N-Methyl-D-Aspartate Receptor Encephalitis: Early Treatment is Beneficial. Pediatric Neurology, 42(3), 213-214 (2010)

  • [89]C. Bayreuther, V. Bourg, J. Dellamonica, M. Borg, G. Bernardin and P. Thomas: Complex partial status epilepticus revealing anti-NMDA receptor encephalitis. Epileptic Disord, 11(3), 261-5 (2009)

  • [90]A. Labate, S. R. Irani, A. Vincent, A. Gambardella, E. Le Piane, V. Cianci and U. Aguglia: Anti-NMDA receptor encephalitis: a video case report. Epileptic Disorders, 11(3), 267-269 (2009)

  • [91]A. R. De Nayer, N. Myant and C. J. Sindic: A subacute behavioral disorder in a female adolescent. Autoimmune anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Biol Psychiatry, 66(6), e13-4 (2009)

  • [92]A. Shindo, K. Kagawa, Y. Ii, R. Sasaki, Y. Kokubo and S. Kuzuhara: Anti-N-Methyl-D-Aspartate Receptor-Related Grave but Reversible Encephalitis with Ovarian Teratoma in 2 Japanese Women Presenting with Excellent Recovery without Tumor Resection. European Neurology, 61(1), 50-51 (2009)

  • [93]M. Seki, S. Suzuki, T. Iizuka, T. Shimizu, Y. Nihei, N. Suzuki and J. Dalmau: Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis. Journal of Neurology Neurosurgery and Psychiatry, 79(3), 324-326 (2008)

Article Metrics

  • Information

  • Download

  • Contents

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Abstract

Treatments for anti-N-methyl-D-aspartate (NMDA) receptor encephalitis include immunotherapy with steroids, intravenous immunoglobulin, plasma exchange, or plasmapheresis as first-line treatments, immunotherapy with rituximab or cyclophosphamide as second-line treatments, and tumor removal. In this systematic review, we evaluated previous studies and examined the association between certain microRNAs and anti-NMDA receptor encephalitis to investigate the performance of different treatment combinations. The efficacies of different combinations of treatments classified into the following four categories were compared: (I) intravenous immunoglobulin administration, (II) plasmapheresis or plasma exchange, (III) treatment with rituximab or cyclophosphamide and (IV) tumor removal. Statistical analyses showed that treatment combinations including at least two of these categories resulted in higher efficacy rates than treatment with a single form of therapy. These findings suggest that if a patient is not recovering, converting to other therapies is more likely to result in early recovery than continuing on the original therapy.

Keywords

  • Anti-NMDA Receptor Encephalitis
  • Treatment
  • Efficacy Rate

References